Paper16782892
Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK "inhibitors".
Bockstaele L and 7 others. Mol Cell Biol, 2006. Cited by 58 papers, by iCite.
Cite this record
ConductScience Library. Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK "inhibitors". Papers, record 16782892. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16782892
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK "inhibitors".
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cyclin-Dependent Kinase 4 | Major topic |
| Cyclin-Dependent Kinase Inhibitor p21 | Major topic |
| Cyclin-Dependent Kinase Inhibitor p27 | Major topic |
| Cyclins | Major topic |
| Nuclear Localization Signals | Major topic |
| Animals | |
| Cells, Cultured | |
| Cytoplasm | |
| Dogs | |
| Enzyme Activation | |
| Humans | |
| Phosphorylation | |
| Receptor Protein-Tyrosine Kinases | |
| Serine | |
| Threonine |
Source PubMed
References94
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7626805 | Inhibition of cyclin-dependent kinases by p21. | Mol Biol Cell | 1995 | https://conductscience.org/library/papers/7626805 | PubMed |
| 2 | 7758941 | Inhibitors of mammalian G1 cyclin-dependent kinases. | Genes Dev | 1995 | https://conductscience.org/library/papers/7758941 | PubMed |
| 3 | 10385618 | CDK inhibitors: positive and negative regulators of G1-phase progression. | Genes Dev | 1999 | https://conductscience.org/library/papers/10385618 | PubMed |
| 4 | 11726500 | Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors. | EMBO J | 2001 | https://conductscience.org/library/papers/11726500 | PubMed |
| 5 | 7478582 | Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. | Oncogene | 1995 | https://conductscience.org/library/papers/7478582 | PubMed |
| 6 | 15486101 | The plant-specific kinase CDKF;1 is involved in activating phosphorylation of cyclin-dependent kinase-activating kinases in Arabidopsis. | Plant Cell | 2004 | https://conductscience.org/library/papers/15486101 | PubMed |
| 7 | 9819350 | Localization and regulation of the cdk-activating kinase (Cak1p) from budding yeast. | J Cell Sci | 1998 | https://conductscience.org/library/papers/9819350 | PubMed |
| 8 | 9989807 | A rate limiting function of cdc25A for S phase entry inversely correlates with tyrosine dephosphorylation of Cdk2. | Oncogene | 1999 | https://conductscience.org/library/papers/9989807 | PubMed |
| 9 | 10903150 | Regulation of cyclin-dependent kinase (Cdk) 2 Thr-160 phosphorylation and activity by mitogen-activated protein kinase in late G1 phase. | Biochem J | 2000 | https://conductscience.org/library/papers/10903150 | PubMed |
| 10 | 7936635 | Cloning, expression and subcellular localization of the human homolog of p40MO15 catalytic subunit of cdk-activating kinase. | Oncogene | 1994 | https://conductscience.org/library/papers/7936635 | PubMed |
| 11 | 12070150 | The proto-oncogene c-myc acts through the cyclin-dependent kinase (Cdk) inhibitor p27(Kip1) to facilitate the activation of Cdk4/6 and early G(1) phase progression. | J Biol Chem | 2002 | https://conductscience.org/library/papers/12070150 | PubMed |
| 12 | 12475985 | Inhibition of cdk2 activating phosphorylation by mevastatin. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12475985 | PubMed |
| 13 | 11960696 | Cyclin D-dependent kinases, INK4 inhibitors and cancer. | Biochim Biophys Acta | 2002 | https://conductscience.org/library/papers/11960696 | PubMed |
| 14 | 11726503 | p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis. | EMBO J | 2001 | https://conductscience.org/library/papers/11726503 | PubMed |
| 15 | 10866826 | Analysis of CAK activities from human cells. | Eur J Biochem | 2000 | https://conductscience.org/library/papers/10866826 | PubMed |
| 16 | 12204530 | The RB and p53 pathways in cancer. | Cancer Cell | 2002 | https://conductscience.org/library/papers/12204530 | PubMed |
| 17 | 15241418 | Cyclin-dependent kinases regulate the antiproliferative function of Smads. | Nature | 2004 | https://conductscience.org/library/papers/15241418 | PubMed |
| 18 | 10188587 | The cdk-activating kinase (CAK): from yeast to mammals. | Cell Mol Life Sci | 1999 | https://conductscience.org/library/papers/10188587 | PubMed |
| 19 | 9774675 | Regulation of exit from quiescence by p27 and cyclin D1-CDK4. | Mol Cell Biol | 1998 | https://conductscience.org/library/papers/9774675 | PubMed |
| 20 | 8458862 | Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts. | J Cell Biol | 1993 | https://conductscience.org/library/papers/8458862 | PubMed |
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42165225 | G0 or no-G0: phosphatase control of quiescence and cell cycle entry. | Biochem Soc Trans | 2026 | https://conductscience.org/library/papers/42165225 | PubMed |
| 41778144 | Uncovering Thyroid Vulnerability to Doxorubicin: Integrative Cellular and in vivo Evidence of Mitochondrial Dysfunction. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/41778144 | PubMed |
| 41606085 | Defining the heterogeneous molecular landscape of lung cancer cell responses to epigenetic inhibition. | Commun Biol | 2026 | https://conductscience.org/library/papers/41606085 | PubMed |
| 41535264 | Multi-center multi-omics integration predicts individualized prognosis in medullary thyroid carcinoma. | Nat Commun | 2026 | https://conductscience.org/library/papers/41535264 | PubMed |
| 39500892 | Hypermethylation of CDKN2A CpG island drives resistance to PRC2 inhibitors in SWI/SNF loss-of-function tumors. | Cell Death Dis | 2024 | https://conductscience.org/library/papers/39500892 | PubMed |
| 37964967 | CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37964967 | PubMed |
| 36884374 | CDK6 activity in a recurring convergent kinase network motif. | FASEB J | 2023 | https://conductscience.org/library/papers/36884374 | PubMed |
| 36765923 | CDK4/6 Inhibitors in Pancreatobiliary Cancers: Opportunities and Challenges. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36765923 | PubMed |
| 36484997 | An Activity-Based Oxaziridine Platform for Identifying and Developing Covalent Ligands for Functional Allosteric Methionine Sites: Redox-Dependent Inhibition of Cyclin-Dependent Kinase 4. | J Am Chem Soc | 2022 | https://conductscience.org/library/papers/36484997 | PubMed |
| 36453028 | Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition. | Mol Oncol | 2024 | https://conductscience.org/library/papers/36453028 | PubMed |
| 36422959 | Target Mechanisms of the Cyanotoxin Cylindrospermopsin in Immortalized Human Airway Epithelial Cells. | Toxins (Basel) | 2022 | https://conductscience.org/library/papers/36422959 | PubMed |
| 36051751 | CDK4: a master regulator of the cell cycle and its role in cancer. | Genes Cancer | 2022 | https://conductscience.org/library/papers/36051751 | PubMed |
| 35264774 | Therapeutic potential of CDK4/6 inhibitors in renal cell carcinoma. | Nat Rev Urol | 2022 | https://conductscience.org/library/papers/35264774 | PubMed |
| 34913830 | Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27. | Cell Cycle | 2022 | https://conductscience.org/library/papers/34913830 | PubMed |
| 33669522 | Ionizing Radiation Protein Biomarkers in Normal Tissue and Their Correlation to Radiosensitivity: A Systematic Review. | J Pers Med | 2021 | https://conductscience.org/library/papers/33669522 | PubMed |
| 33553144 | Progression Risk Assessment of Post-surgical Papillary Thyroid Carcinoma Based on Circular RNA-Associated Competing Endogenous RNA Mechanisms. | Front Cell Dev Biol | 2020 | https://conductscience.org/library/papers/33553144 | PubMed |
| 32344731 | CDKs in Sarcoma: Mediators of Disease and Emerging Therapeutic Targets. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32344731 | PubMed |
| 31665700 | Long noncoding RNA ARHGAP27P1 inhibits gastric cancer cell proliferation and cell cycle progression through epigenetically regulating p15 and p16. | Aging (Albany NY) | 2019 | https://conductscience.org/library/papers/31665700 | PubMed |
| 28566333 | CDK4 phosphorylation status and a linked gene expression profile predict sensitivity to palbociclib. | EMBO Mol Med | 2017 | https://conductscience.org/library/papers/28566333 | PubMed |
| 28368408 | JNKs function as CDK4-activating kinases by phosphorylating CDK4 and p21. | Oncogene | 2017 | https://conductscience.org/library/papers/28368408 | PubMed |
Genes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16782892
GET https://conductscience.org/api/papers/v1/16782892/references?page=2